Changes in bone mass and bone turnover following tibial shaft fracture
- PMID: 16362144
- DOI: 10.1007/s00198-005-2025-y
Changes in bone mass and bone turnover following tibial shaft fracture
Abstract
Introduction: Bone loss occurs in the regional bone following tibial shaft fracture. An earlier cross-sectional study showed that measurements made at the metaphyseal region of the tibia using peripheral quantitative computed tomography (pQCT) and the ultradistal region of the tibia using dual-energy X-ray absorptiometry (DXA) were the most responsive at monitoring this bone loss. Biochemical markers of bone turnover enable us to assess the activity of bone formation and resorption during fracture healing. The aim of this longitudinal study was to determine the pattern and distribution of bone loss and bone turnover following a tibial shaft fracture treated with either plaster cast or intramedullary nail.
Methods: Eighteen subjects underwent bone mass measurements using DXA at the tibia and hip and quantitative ultrasound (QUS) at the tibia and calcaneus of both limbs at 2 weeks, 8 weeks, 12 weeks and 24 weeks following fracture, with hip and tibia DXA measurements also performed at 52 weeks. Nine of the patients treated with plaster cast had pQCT measurements at the tibia at 24 weeks. We measured three bone formation markers, bone alkaline phosphatase (bone ALP), osteocalcin (OC) and procollagen type 1 N-terminal peptide (PINP), a marker of bone resorption, serum C-telopeptides of type 1 collagen (beta-CTX) and a marker of collagen III turnover, procollagen type III N-terminal peptide (PIIINP) at 1 day, 3 days and 7 days and at 2, 4, 8, 12, 16 and 24 weeks following fracture. The greatest bone losses were observed at the ultradistal region of the tibia using DXA (28%, p <0.001) and the metaphyseal region of the tibia using pQCT (26-31%, p <0.001) at 24 weeks. In the hip, the greatest loss was in the trochanter region at 24 weeks (10%, p <0.001). The greatest loss at the calcaneus measured using QUS was for broadband ultrasound attenuation (BUA) measured using CUBA Clinical at 24 weeks (13%, p =0.01).
Results: At 1 year, there was a small recovery in bone loss (ultradistal tibia DXA, 20%, p <0.01; trochanter DXA 9%, p <0.001). Bone turnover increased following fracture (PINP +72+/-21%, p <0.0001, bone ALP +199+/-22%, p =0.004, beta-CTX +105+/-23%, p <0.0001, all at 24 weeks). There was a smaller +33+/-10% increase in osteocalcin at 24 weeks. PIIINP concentration peaked at week 8 (+57+/-9%, p <0.0001). The bone resorption marker beta-CTX showed an earlier rise (week 2, 139+/-33%) than the bone formation markers.
Conclusions: We conclude that: (1) bone loss following tibial shaft fracture occurs both proximal and distal to the fracture; (2) the decreased BMD is largest for trabecular bone in the tibia with similar measurements using DXA and pQCT; (3) there is limited recovery of bone lost at the hip and tibia at 1 year; (4) tibial speed of sound (SOS) demonstrated a greater decrease than calcaneal SOS when comparing z -scores; (5) BUA is the QUS variable that shows the biggest decrease of bone mass at the calcaneus; (6) increase in bone turnover occurs following fracture with an earlier increase in bone resorption markers and a later rise in bone formation markers.
Similar articles
-
Changes in bone mass and bone turnover following ankle fracture.Osteoporos Int. 1999;10(5):408-15. doi: 10.1007/s001980050247. Osteoporos Int. 1999. PMID: 10591839
-
Changes in bone mass and bone turnover following distal forearm fracture.Osteoporos Int. 1999;10(5):399-407. doi: 10.1007/s001980050246. Osteoporos Int. 1999. PMID: 10591838
-
Measurement of bone adjacent to tibial shaft fracture.Osteoporos Int. 2002 Dec;13(12):980-9. doi: 10.1007/s001980200136. Osteoporos Int. 2002. PMID: 12459941
-
Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti-Resorptive Drugs: A Meta-Regression.J Bone Miner Res. 2018 Apr;33(4):634-642. doi: 10.1002/jbmr.3355. Epub 2018 Jan 10. J Bone Miner Res. 2018. PMID: 29318649
-
Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.Osteoporos Int. 2017 Sep;28(9):2541-2556. doi: 10.1007/s00198-017-4082-4. Epub 2017 Jun 19. Osteoporos Int. 2017. PMID: 28631236 Review.
Cited by
-
Bone turnover markers: use in osteoporosis.Nat Rev Rheumatol. 2012 Jun 5;8(7):379-89. doi: 10.1038/nrrheum.2012.86. Nat Rev Rheumatol. 2012. PMID: 22664836 Review.
-
The clinical utility of bone marker measurements in osteoporosis.J Transl Med. 2013 Aug 29;11:201. doi: 10.1186/1479-5876-11-201. J Transl Med. 2013. PMID: 23984630 Free PMC article. Review.
-
Current Options for Determining Fracture Union.Adv Med. 2014;2014:708574. doi: 10.1155/2014/708574. Epub 2014 Sep 14. Adv Med. 2014. PMID: 26556422 Free PMC article. Review.
-
Amorphous Calcium Carbonate Enhances Fracture Healing in a Rat Fracture Model.Nutrients. 2024 Nov 27;16(23):4089. doi: 10.3390/nu16234089. Nutrients. 2024. PMID: 39683484 Free PMC article.
-
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).Osteoporos Int. 2025 Apr;36(4):579-608. doi: 10.1007/s00198-025-07422-3. Epub 2025 Mar 28. Osteoporos Int. 2025. PMID: 40152990 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous